Peptide Chemistry Conference 2012
|Chairs||Ram Sharma (University of Southampton)
Patrick Kanda (Health Protection Agency)
|Date||Saturday November 3 2012 - Tuesday November 6 2012|
|Advertising Opportunities||Please contact us to discuss advertising, exhibition & sponsorship opportunities at the Peptide Chemistry conference.|
|Synopsis||The interest of pharmaceutical companies for peptides is increasing enormously in the last decade. There are several reasons for that. In first place, the number of the so-called small molecules accepted for the corresponding agencies are declining. In this sense, pharmaceutical are looking more to biological based drugs. Furthermore, the advances in fields of formulation, drug delivery technology and chemical modifications, have rekindled the interest in peptides as APIs.
This would not be possible without the concurrence of strong peptide chemistry. The development of new resins for the solid-phase methodology, coupling reagents, orthogonal protecting groups, and synthetic strategies are being allowed the rapid and efficient synthesis of small and large peptides for research and, then, the multi-ton preparation of the API based peptides.
This Zing conference will be totally devoted into the last development on peptide chemistry. In addition to the parameters outlined above, the following topics will be discussed:
|Confirmed oral presentations||
Programme · Talk Titles
Sorry, but all abstract deadlines have passed.
To secure your place at the conference, register now.
|Register now () to secure your place.|
Multiple attendance discount: 3 or more members from the same lab are eligible for a discount. Please contact us.
Multiple conference discount: We can offer you a discount if you wish to attend multiple conferences. Please contact us.
Amram Mor (Israel Institute of Technology)
Chemo-sensitisation of multidrug resistant bacteria
Brian Austen (St George's University of London)
SYNTHESIS and CHARACTERISATION OF Gd-LINKED AMYLOID-BINDING PEPTIDES FOR MRI DIAGNOSIS OF ALZHEIMER?S DISEASE
David Craik (The University of Queensland)
Ribosomally synthesized cyclic peptides: opportunities to produce peptide-based pharmaceuticals in plants.
Eagle Huang (National Defense Medical Center)
LVV-hemorphin 7, angiotensin IV, and oxytocin in regulation of pain at the spinal cord
Ed Nice (Monash University)
Development of Layer-by-Layer (LbL) nanocapsules for effective drug delivery to colorectal cancer
Eric Biron (Laval University)
New ring-opening approaches for the synthesis and decoding of cyclic peptide libraries
Fernando Albericio (Institute for Research in Biomedicine (IRB Barcelona))
Hidehito Mukai (Nagahama Institute of Bio-Science and Technology)
Cryptides: Identification of Novel Bioactive Peptides Hidden within Protein Sequences
Jane Aldrich (University of Kansas, Department of Medicinal Chemistry)
Novel Opioid Peptides as Potential Treatments for Pain and Drug Abuse
Joel Lindgren (Royal Institute of Technology (KTH), Dept of Molecular Biotechnology)
A Native Chemical Ligation Approach for Combinatorial Assembly of Affibody Molecules
John McMurray (MD Anderson Cancer Center)
Delivery of phosphopeptides to cells and tissues. Targeting the SH2 domains of STAT3 and STAT6
Jon Nissen-Meyer (University of Oslo, Department of Molecular Biosciences)
The Structure and Mode-of-Action of the Unmodified Antibacterial Peptides (i.e. Bacteriocins) Produced by Lactic Acid Bacteria
Jung-Mo Ahn (The University of Texas at Dallas)
Rational Design of Peptidomimetics to Inhibit Androgen Receptor in Prostate Cancer
Jutta Eichler (University Erlangen-Nurnberg )
Probing Host - Pathogen Interactions using Scaffolded and Assembled Peptides as Protein Binding Site Mimetics
karin thevissen (KU Leuven)
Antifungal and antibiofilm peptides
Luca Gentilucci (University of Bologna)
Ready synthesis of oxazolidinone-containing peptides; conformational aspects and applications for the design of bioactive compounds.
Maria Teresa Machini (Universidade de S?o Paulo )
Synthetic hemocidin Hb40-61a: study on its properties, mechanism of action and interaction with polymeric nanoparticles
Matthieu Giraud (BASF Pharma)
Maurice Manning (The University of Toledo Health Science Campus)
New Horizons in the Development of Peptides as Therapeutic agents and as Research Tools
Paul Alewood (The University of Queensland)
Folding mini-proteins via disulfide bond mimetics
Phil Dawson (Scripps Research Institute)
Reto Stocklin (Atheris Laboratories)
Richard Williams (Deakin University )
Self-Assembled peptides: Scaffolds for regenerative medicine
Robin Leatherbarrow (Imperial College London)
Robin Offord (Mintaka Foundation)
Modern peptide and protein chemistry in the service of the developing world: Hi Tech or Low Tech?
Robin Polt (The University of Arizona)
Glycosylated Neuropeptide Transmitters as CNS Drugs.
ROSARIO GONZALEZ-MUNIZ (Instituto de Qu?mica M?dica-CSIC)
Azepane-derived quaternary amino acid: Synthesis and ability to induce 310 helix structures
Sabine Fenner (University of Cambridge, Department of Chemistry)
Towards the Total Synthesis of Plantazolicin A
Shigemi Matsuyama (Case Western Reserve University)
Cell Penetrating PentaPeptide (CPP5): Cytoprotection and Protein Transduction Activity
Stephen Kent (University of Chicago)
Chemical Protein Synthesis and Its Applications
William Lubell (University of Montreal )
Aza-amino acid analogs for constraining conformation and studying peptide biology.
Yasuhiro Kajihara (Osaka University, Department of Chemistry)
Design and synthesis of homogeneous glycoproteins for the elucidation of oligosaccharide functions